Led · Seed · Feb 2023

Brevity delivers AI-driven software intended to guide users toward funding, contracts, and desired outcomes via pitch and presentation communications. The product leverages AI to create effective pitch and presentation language for entrepreneurs, business professionals, and others who lack specialized messaging expertise. Founders Kelvin Johnson Jr. and Maximilian Huc started Brevity to help users raise capital, grow sales, and close contracts. Since 2020 the platform has enabled users to raise millions in capital, grow sales, and close contracts. In 2022 Brevity’s software was integral in securing a contract worth over $24 million more than the company closed independently the year before. Brevity is participating in Lightship Foundation’s Tulsa, Oklahoma Accelerator program and will continue to have access to Lightship’s startup growth programming.

Participated · Series A · Sep 2022

Proov (MFB Fertility, Inc.) develops at-home hormone tests and created the first and only FDA-cleared PdG-testing kit to confirm ovulation quality. Its patented PdG protocol and the Proov Insight app provide quantitative hormone results, end-of-cycle reports, and stored hormone trends without an external reader. The company expanded its product lineup to include Proov Predict & Confirm and has launched Proov Complete, an at-home suite that measures FSH, LH, E1G (estrogen marker) and PdG. Proov says the Complete product and app deliver a comprehensive and affordable at-home hormonal pattern analysis across the menstrual cycle. The company was originally co-founded in Boulder, Colo. by two women who struggled to conceive and is led by CEO Amy Beckley. Proov raised a Series A to support the Complete product and to expand accessibility and physician partnerships. Proov is an at-home fertility diagnostics company launched by MFB Fertility Inc. in 2018 and co-founded in Boulder, Colorado by two women who struggled to conceive. Its FDA-approved test measures the progesterone metabolite PdG in urine to help women confirm ovulation; low progesterone is cited as a leading cause of infertility and preventable miscarriage. Demand for at-home testing kits has surged amid Covid-19, driving the company to scale production and accelerate research and development. The company recently received undisclosed funding from Lightship Capital and the Texas HALO Fund, plus additional angel investors, to support growth and new product launches. Proov also holds a $1.3 million contract with the U.S. Air Force to provide free kits and connect military couples with fertility specialists. CEO Amy Beckley said the investment will help Proov expand its product offering and continue developing fertility tools to deliver more accessible reproductive-health solutions.

Led · Seed · Mar 2022

Vyrill offers an AI-driven in-video search, analytics and video-commerce solution that identifies brand engagement content online. Its technology enables brands to know their customers/fans, interact with them directly, and implement targeted marketing strategies featuring video. The company was launched in 2017 through UC Berkeley’s SkyDeck incubator and was founded by Ajay Bam and Dr. Barbara Rosario. In March 2022 Vyrill closed a $3M seed funding round. The startup intends to use the funds to extend its technology to e-commerce platforms, grow the team, and expand its product offering to more businesses worldwide. Vyrill targets brands seeking to leverage video content for commerce and audience insights.

Participated · Seed · Feb 2022

Bootup operates a tech talent marketplace whose main customers are large enterprises building tech talent pipelines and bootcamps seeking placements for students. The platform allows users with no experience to discover suitable tech roles and is free for talent, while companies and bootcamps pay a 10% commission. After launching its initial product in July, Bootup reported rapid revenue growth—doubling from July to August, doubling again from August to September, and securing a contract in September expected to double revenue once more. The company reports that one out of every nine applicants is hired through the platform. Bootup plans to use the new funding to hire engineers to develop the platform and launch new features, and the team is considering expansion into the Latin American market. Executives are based in Miami while the customer service team remains in Tulsa.

Participated · Series A · Dec 2021

MFB Fertility, known commercially as Proov, develops at-home urine hormone tests—most notably a PdG test that measures a progesterone metabolite to confirm ovulation quality. The company received 510(k) clearance from the FDA for its PdG urine test in February 2020 and markets a suite of pregnancy-related hormone tests. Proov has rolled out a mobile app that uses machine-learning to score test-strip photos, provide ovulation scores, allow sharing with doctors, connect users with experts, and deliver lifestyle guidance. The company is developing a “complete” testing product that includes PdG, LH, FSH and an estrogen marker and is building an integrated supplement platform tied to the app. Proov has reported clinical-trial data (one unpublished trial of 54 pregnant women) suggesting PdG patterns may relate to miscarriage risk, though that data has not been peer reviewed or published. The company was founded in 2018 by CEO Amy Beckley and recently closed a Series A, indicating early-stage commercialization and growth funding.